Role of RanBP9 on dendritic and spine injury in an Alzheimer's mouse model
RanBP9 对阿尔茨海默病小鼠模型树突和脊柱损伤的作用
基本信息
- 批准号:8446997
- 负责人:
- 金额:$ 27.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2014-09-30
- 项目状态:已结题
- 来源:
- 关键词:55-kDa Ran-binding proteinAddressAdhesionsAgeAge-MonthsAlzheimer&aposs DiseaseAmino AcidsAmyloidAmyloid ProteinsAmyloid beta-Protein PrecursorAmyloid depositionApolipoprotein EAppearanceBackBehavioralBindingBinding ProteinsBrainBrain regionCell LineCell NucleusCell Surface ReceptorsCell membraneCell surfaceCellular MorphologyCharacteristicsCognitive deficitsComplexComputer softwareCytoplasmDendritic SpinesFormic AcidsFutureGenerationsGoalsGrantGrowthHippocampus (Brain)HybridsImageImmunoblottingInterventionIntracellular MembranesKnockout MiceLDL-Receptor Related Protein 1LasersLate Onset Alzheimer DiseaseLearningLengthLigandsLipoprotein ReceptorMacroglobulinsMediatingMembrane MicrodomainsMembrane Protein TrafficMemoryMemory LossMemory impairmentMicroscopeModelingMolecularMusMutationNeuritesNeurofibrillary TanglesNeuronsPartner in relationshipPathogenesisPathologyPatientsPatternPeptidesProductionProtein BindingProteinsResearchRisk FactorsRoleScaffolding ProteinScanningScreening ResultSenile PlaquesSignal TransductionSpinal GangliaSpinal InjuriesStaining methodStainsSurfaceSynapsesTestingTherapeuticTimeTransfectionTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthVertebral columnYeastsabstractingamyloid precursor protein processingbasebeta-site APP cleaving enzyme 1densitydesignfrontal lobegenetic associationhippocampal pyramidal neuronhuman RTN4 proteinimprovedin vivoinnovationinsightlucifer yellowmouse modelmultiple myeloma M Proteinneuronal cell bodynovelnovel therapeuticspostsynapticpresynapticprotein Bprotein metabolismsecretaseskills
项目摘要
Project Summary/Abstract
Alzheimer¿s disease (AD) is characterized by the deposition of amyloid Bprotein (AB), a small peptide derived
from B- and y-secretase cleavages of the amyloid precursor protein (APP). We recently demonstrated that the
last 37 amino acids (LRP-C37) of low-density lipoprotein receptor-related protein (LRP) without the NPXY
motifs to be necessary and sufficient to increase ABproduction. Since LRP-C37 alone was a potent inducer of
ABproduction, we used this domain as bait in a yeast 2-hybrid screen, resulting in the identification of Ranbinding
protein M (RanBP9). Indeed transient transfections of APP and RanBP9-FL or FL-derived RanBP9-
N60 robustly increased secretion of ABin varieties of cell lines, indicating that RanBP9 alters APP metabolism.
Most importantly, immunoblot quantification of RanBP9 protein levels demonstrated that RanBP9-N60 and
RanBP9-FL were elevated more than six and four-folds in the brains of AD patients and APP J20 transgenic
mice respectively. We also found that like LRP and two of its key ligands, RanBP9 is genetically associated
with late-onset AD. To gain a better insight on the in vivo role of RanBP9 in the pathogenesis of AD, we
generated transgenic mice over expressing RanBP9 in the brain as a part of an ongoing NIH R03 grant. By
crossing B6C3-Tg85Dbo mice (APdE9) carrying APPswe, PSEN1dE9 mutations with RanBP9 transgenic
mice, RanBP9/APdE9 triple transgenic mice were generated, which produced more CHAPSO-soluble ABand
c-terminal fragments (CTFs) compared to APdE9 mice as early as 3 months of age, suggesting that RanBP9
increases amyloidogenic processing of APP in vivo. This R01 proposal is an extension of the R03 project.
As loss of synapses is a better correlate of the extent of cognitive deficits in Alzheimer¿s patients and since
RanBP9 is present in substantial amounts in neurites and is a strong inhibitor of neurite outgrowth, we next
want to examine in this proposal, whether RanBP9-induced altered processing of APP also leads to dendritic
and spine injury. We have successfully produced RanBP9 transgenic mice as well as heterozygous null mice
for the first time. We propose to compare the pattern of dendritic arborization, spine density, presynaptic and
postsynaptic protein levels in the hippocampus and frontal cortex followed by tests for learning and memory
skills at 2, 5 and 10 months of age in eight groups of mice, i.e., RanBP9-629 single transgenic, APdE9 double
transgenic, RanBP9-629/APdE9 triple transgenic, RanBP9-599 single transgenic, RanBP9-599/APdE9 triple
transgenic, RanBP9-/- or RanBP9+/-, RanBP9-/- or RanBP9+/-/APdE9 and wild type litter-mate controls.
Neuron Studio, software for automated spine density analysis, will be used to analyze dendritic branching
points and spine numbers in Lucifer-yellow-stained pyramidal neurons after obtaining images by laser
scanning confocal microscope. If RanBP9 is confirmed as a bona fide target in vivo in this study, the triple
transgenic mice may prove to be useful as an accelerated model for synaptic and behavioral deficits.
项目总结/摘要
阿尔茨海默病(AD)的特征是淀粉样蛋白B蛋白(AB)的沉积,
来自淀粉样前体蛋白(APP)的B-和γ-分泌酶裂解。我们最近证明,
不含NPXY的低密度脂蛋白受体相关蛋白(LRP)的最后37个氨基酸(LRP-C37)
基序是必要的和足够的,以增加AB生产。由于单独的LRP-C37是一种有效的诱导剂,
AB生产,我们使用这个结构域作为酵母双杂交筛选的诱饵,导致Ranbinding的鉴定
蛋白M(RanBP 9)。事实上,APP和RanBP 9-FL或FL-衍生的RanBP 9-FL的瞬时转染是有效的。
N60在各种细胞系中强烈增加AB的分泌,表明RanBP 9改变APP代谢。
最重要的是,RanBP 9蛋白水平的免疫印迹定量表明RanBP 9-N60和N60-N70蛋白表达量增加。
RanBP 9-FL在AD患者和APP J20转基因患者的脑中升高超过6倍和4倍。
小鼠分别。我们还发现,像LRP和它的两个关键配体一样,RanBP 9与LRP的基因相关,
晚发性AD为了更好地了解RanBP 9在AD发病机制中的体内作用,我们
作为正在进行的NIH R 03资助的一部分,产生了在大脑中过度表达RanBP 9的转基因小鼠。通过
将携带APPswe、PSEN 1dE 9突变的B6 C3-Tg 85 Dbo小鼠(APdE 9)与RanBP 9转基因小鼠杂交,
在小鼠中,产生RanBP 9/APdE 9三重转基因小鼠,其产生更多的CHAPSO可溶性AB和
早在3个月大时,与APdE 9小鼠相比,RanBP 9小鼠的c-末端片段(CTF)就已表达,这表明RanBP 9
增加体内APP的淀粉样蛋白形成过程。本R 01提案是R 03项目的延伸。
由于突触的丧失与阿尔茨海默病患者的认知缺陷程度有更好的相关性,
RanBP 9在神经突中大量存在,并且是神经突生长的强抑制剂,我们接下来
我想在这个提议中检查RanBP 9诱导的APP加工改变是否也导致树突状细胞的凋亡。
和脊柱损伤我们已经成功地产生了RanBP 9转基因小鼠以及杂合无效小鼠
第一次我们建议比较树突分支的模式,棘密度,突触前和
海马体和额叶皮层的突触后蛋白水平,随后进行学习和记忆测试
技能在2,5和10个月大的八组小鼠,即,RanBP 9 -629单转基因,APdE 9双转基因
转基因,RanBP 9 -629/APdE 9三转基因,RanBP 9 -599单转基因,RanBP 9 -599/APdE 9三转基因
转基因、RanBP 9-/-或RanBP 9 +/-、RanBP 9-/-或RanBP 9 +/-/APdE 9和野生型同窝交配对照。
Neuron Studio是一种用于自动脊柱密度分析的软件,将用于分析树突分支
激光成像后荧光黄染色锥体神经元的点和棘数
扫描共聚焦显微镜如果RanBP 9在本研究中被证实为体内真正的靶点,则三重
转基因小鼠可以被证明是有用的作为一个加速模型的突触和行为缺陷。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents.
取代的二硫唑哌嗪苯甲酰胺作为新型淀粉样β肽还原剂。
- DOI:10.1016/j.bmcl.2014.08.022
- 发表时间:2014-09-15
- 期刊:
- 影响因子:2.7
- 作者:Wang, Hongjie;Wang, Ruizhi;Lakshmana, Madepalli K.;Nefzi, Adel
- 通讯作者:Nefzi, Adel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Madepalli Krishnappa Lakshmana其他文献
Madepalli Krishnappa Lakshmana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Madepalli Krishnappa Lakshmana', 18)}}的其他基金
A LncRNA in Pulmonary Mucosal Immunity and HIV-Associated Comorbidities
肺粘膜免疫和 HIV 相关合并症中的 LncRNA
- 批准号:
10252766 - 财政年份:2020
- 资助金额:
$ 27.11万 - 项目类别:
A LncRNA in Pulmonary Mucosal Immunity and HIV-Associated Comorbidities
肺粘膜免疫和 HIV 相关合并症中的 LncRNA
- 批准号:
10406519 - 财政年份:2020
- 资助金额:
$ 27.11万 - 项目类别:
Novel role of TFEB in ADAM10 potentiation and proliferation of neural precursor cells relevant to Alzheimer's disease
TFEB 在 ADAM10 增强和与阿尔茨海默病相关的神经前体细胞增殖中的新作用
- 批准号:
9981582 - 财政年份:2019
- 资助金额:
$ 27.11万 - 项目类别:
Role of RanBP9 on dendritic and spine injury in an Alzheimer's mouse model
RanBP9 对阿尔茨海默病小鼠模型树突和脊柱损伤的作用
- 批准号:
8045453 - 财政年份:2010
- 资助金额:
$ 27.11万 - 项目类别:
Role of RanBP9 on dendritic and spine injury in an Alzheimer's mouse model
RanBP9 对阿尔茨海默病小鼠模型树突和脊柱损伤的作用
- 批准号:
8235773 - 财政年份:2010
- 资助金额:
$ 27.11万 - 项目类别:
Role of RanBP9 on dendritic and spine injury in an Alzheimer's mouse model
RanBP9 对阿尔茨海默病小鼠模型树突和脊柱损伤的作用
- 批准号:
8067637 - 财政年份:2010
- 资助金额:
$ 27.11万 - 项目类别:
Effect of RanbpM on amyloid pathology in a mouse model of Alzheimer's disease
RanbpM 对阿尔茨海默病小鼠模型淀粉样蛋白病理学的影响
- 批准号:
7678523 - 财政年份:2008
- 资助金额:
$ 27.11万 - 项目类别:
Effect of RanbpM on amyloid pathology in a mouse model of Alzheimer's disease
RanbpM 对阿尔茨海默病小鼠模型淀粉样蛋白病理学的影响
- 批准号:
7449214 - 财政年份:2008
- 资助金额:
$ 27.11万 - 项目类别:
Effect of RanbpM on amyloid pathology in a mouse model of Alzheimer's disease
RanbpM 对阿尔茨海默病小鼠模型淀粉样蛋白病理学的影响
- 批准号:
8067642 - 财政年份:2008
- 资助金额:
$ 27.11万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 27.11万 - 项目类别:
Research Grant